Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Emslie

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|February 3, 2009
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment responseJoan Rosenbaum Asarnow, Graham Emslie, Greg Clarke, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 22, 2004
AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacologyJohn March, Christopher Kratochvil, Gregory Clarke, et al.
Journal of Consulting and Clinical Psychology|January 19, 2012
Onset of alcohol or substance use disorders following treatment for adolescent depressionJohn Curry, Susan Silva, Paul Rohde, et al.
Archives of General Psychiatry|November 3, 2010
Recovery and recurrence following treatment for adolescent major depressionJohn Curry, Susan Silva, Paul Rohde, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sampleBenedetto Vitiello, Graham Emslie, Gregory Clarke, et al.
JAMA|March 4, 2008
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trialDavid Brent, Graham Emslie, Greg Clarke, et al.
The Journal of Clinical Psychiatry|September 27, 2019
CorrectionBenedetto Vitiello, Graham Emslie, Gregory Clarke, et al.
Archives of General Psychiatry|March 9, 2011
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findingsFrances L Lynch, John F Dickerson, Greg Clarke, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2003
Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conferenceGabrielle A Carlson, Peter S Jensen, Robert L Findling, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 22, 2010
Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) StudyBenedetto Vitiello, David A Brent, Laurence L Greenhill, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of the American Academy of Child and Adolescent Psychiatry|February 3, 2009
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment responseJoan Rosenbaum Asarnow, Graham Emslie, Greg Clarke, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 22, 2004
AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacologyJohn March, Christopher Kratochvil, Gregory Clarke, et al.
Journal of Consulting and Clinical Psychology|January 19, 2012
Onset of alcohol or substance use disorders following treatment for adolescent depressionJohn Curry, Susan Silva, Paul Rohde, et al.
Archives of General Psychiatry|November 3, 2010
Recovery and recurrence following treatment for adolescent major depressionJohn Curry, Susan Silva, Paul Rohde, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sampleBenedetto Vitiello, Graham Emslie, Gregory Clarke, et al.
JAMA|March 4, 2008
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trialDavid Brent, Graham Emslie, Greg Clarke, et al.
The Journal of Clinical Psychiatry|September 27, 2019
CorrectionBenedetto Vitiello, Graham Emslie, Gregory Clarke, et al.
Archives of General Psychiatry|March 9, 2011
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findingsFrances L Lynch, John F Dickerson, Greg Clarke, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2003
Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conferenceGabrielle A Carlson, Peter S Jensen, Robert L Findling, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 22, 2010
Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) StudyBenedetto Vitiello, David A Brent, Laurence L Greenhill, et al.
Pageof 7